Fulgent Genetics, Inc. (FLGT)

Fulgent Genetics Income Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Revenue	303.22	283.47	289.21	618.97	992.58	421.71
Revenue Growth (YoY)	4.31%	-1.99%	-53.27%	-37.64%	135.37%	1196.46%
Cost of Revenue	181.82	176.26	184.76	252.07	215.53	89.81
Gross Profit	121.4	107.22	104.46	366.9	777.05	331.91
Selling, General & Admin	136.39	124.35	130.47	149.99	75.17	30.17
Research & Development	49.77	48.82	41.44	28.91	24.22	11.58
Operating Expenses	194.12	181.13	179.75	185.4	101.1	41.75
Operating Income	-72.72	-73.92	-75.3	181.5	675.95	290.16
Interest Expense	-0.03	-	-0.49	-1.01	-0.18	-
Interest & Investment Income	32.32	31.3	21.61	5.62	0.34	1.44
Earnings From Equity Investments	-	-	-	-	-	-0.49
Other Non Operating Income (Expenses)	0.62	0.73	0.32	0.89	-	-
EBT Excluding Unusual Items	-39.81	-41.88	-53.85	187	676.11	291.11
Merger & Restructuring Charges	-	-	-	-2.98	-	-
Impairment of Goodwill	-	-	-120.23	-	-	-
Gain (Loss) on Sale of Investments	-10.07	-10.07	-	-	4.92	-4.26
Pretax Income	-59.81	-51.96	-174.09	184.03	681.03	286.84
Income Tax Expense	-7.77	-8.14	1.15	42.1	174.8	72.53
Earnings From Continuing Operations	-52.04	-43.82	-175.24	141.92	506.24	214.31
Net Income to Company	-52.04	-43.82	-175.24	141.92	506.24	214.31
Minority Interest in Earnings	1.02	1.11	7.41	1.48	1.13	-
Net Income	-51.02	-42.71	-167.83	143.4	507.36	214.31
Net Income to Common	-51.02	-42.71	-167.83	143.4	507.36	214.31
Net Income Growth	-	-	-	-71.74%	136.74%	-
Shares Outstanding (Basic)	31	30	30	30	29	23
Shares Outstanding (Diluted)	31	30	30	31	31	24
Shares Change (YoY)	2.34%	1.51%	-3.81%	-0.04%	28.77%	28.58%
EPS (Basic)	-1.67	-1.41	-5.63	4.76	17.25	9.44
EPS (Diluted)	-1.67	-1.41	-5.63	4.63	16.38	8.91
EPS Growth	-	-	-	-71.73%	83.84%	-
Free Cash Flow	-59.95	-19.26	4.8	234.75	514.77	105.5
Free Cash Flow Per Share	-1.96	-0.64	0.16	7.58	16.62	4.39
Gross Margin	40.04%	37.82%	36.12%	59.28%	78.29%	78.70%
Operating Margin	-23.98%	-26.08%	-26.03%	29.32%	68.10%	68.81%
Profit Margin	-16.83%	-15.07%	-58.03%	23.17%	51.12%	50.82%
Free Cash Flow Margin	-19.77%	-6.79%	1.66%	37.92%	51.86%	25.02%
EBITDA	-48.64	-48.99	-49.15	214.16	686.96	293.12
EBITDA Margin	-16.04%	-17.28%	-16.99%	34.60%	69.21%	69.51%
D&A For EBITDA	24.09	24.93	26.14	32.66	11	2.96
EBIT	-72.72	-73.92	-75.3	181.5	675.95	290.16
EBIT Margin	-23.98%	-26.08%	-26.03%	29.32%	68.10%	68.81%
Effective Tax Rate	-	-	-	22.88%	25.67%	25.29%

Updated Aug 1, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q